Yan Mao Selected Research

Yan Mao Research Topics

Disease

30	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2013
25	Neoplasms (Cancer) 01/2024 - 01/2006
7	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2016
5	Cataract (Cataracts) 02/2024 - 01/2021
5	Inflammation (Inflammations) 10/2023 - 10/2018
4	Pre-Eclampsia (Preeclampsia) 01/2024 - 11/2018
3	Asthma (Bronchial Asthma) 03/2023 - 04/2019
2	Frailty 02/2024 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2023
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2014
2	Triple Negative Breast Neoplasms 03/2022 - 01/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2015
2	Nasopharyngeal Carcinoma 11/2021 - 07/2013
2	Hypoxia (Hypoxemia) 01/2021 - 01/2014
2	Down Syndrome (Down's Syndrome) 06/2020 - 01/2016
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 04/2020 - 01/2019
2	Aneuploidy (Aneuploid) 12/2018 - 01/2016
2	Carcinogenesis 04/2017 - 12/2012
2	Obesity 05/2015 - 01/2015
1	Sepsis (Septicemia) 04/2024
1	Neuroinflammatory Diseases 04/2024
1	Macular Degeneration (Age-Related Maculopathy) 02/2024
1	Sarcopenia 02/2024
1	Newcastle Disease 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Vascular Remodeling 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Leiomyoma (Uterine Fibroids) 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Psoriatic Arthritis 10/2023
1	Bronchopulmonary Dysplasia 07/2023
1	Osteoporosis 03/2023
1	Airway Remodeling 03/2023
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2013
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2018
8	Estrogen ReceptorsIBA 10/2020 - 01/2013
5	Hormones (Hormone)IBA 01/2023 - 04/2017
5	Long Noncoding RNAIBA 01/2022 - 10/2018
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 08/2013
4	Indicators and Reagents (Reagents)IBA 02/2024 - 01/2013
4	human ERBB2 proteinIBA 01/2023 - 02/2016
3	CytokinesIBA 04/2024 - 06/2021
3	Transcription Factors (Transcription Factor)IBA 01/2024 - 12/2012
3	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2020
3	Ethanol (Ethyl Alcohol)IBA 12/2023 - 04/2019
3	Messenger RNA (mRNA)IBA 01/2023 - 04/2020
3	Tamoxifen FDA LinkGeneric 04/2017 - 10/2013
2	MyokinesIBA 01/2024 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2023
2	Circular RNAIBA 01/2024 - 01/2020
2	Hematoxylin (Haematoxylon)IBA 12/2023 - 04/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 04/2020
2	OvalbuminIBA 03/2023 - 04/2019
2	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2015
2	AntioxidantsIBA 01/2023 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2014
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 08/2021
2	LipopolysaccharidesIBA 01/2022 - 04/2019
2	exemestane (Aromasin)FDA Link 01/2022 - 10/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2016
2	Cell-Free Nucleic AcidsIBA 04/2020 - 01/2019
2	Phenobarbital (Luminal)FDA Link 04/2020 - 08/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2024
1	Food Additives (Food Additive)IBA 04/2024
1	InflammasomesIBA 04/2024
1	IronIBA 02/2024
1	IonsIBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2024
1	CalciumIBA 01/2024
1	AdipokinesIBA 01/2024
1	Angiotensin IIIBA 01/2024
1	Glutamine (L-Glutamine)FDA Link 01/2024
1	BilirubinIBA 10/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2023
1	N-methyladenosineIBA 10/2023
1	Advanced Glycation End ProductsIBA 03/2023
1	Becaplermin (PDGF-BB)FDA Link 03/2023
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 03/2023
1	TabletsIBA 03/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023
1	CreatinineIBA 01/2023
1	HMGN1 Protein (HMGN1)IBA 01/2023
1	PolymersIBA 01/2023
1	acteosideIBA 01/2023
1	AutoantibodiesIBA 01/2023

Therapy/Procedure

8	Therapeutics 03/2022 - 10/2013
6	Neoadjuvant Therapy 10/2023 - 01/2014
4	Immunotherapy 03/2022 - 01/2022
4	Drug Therapy (Chemotherapy) 08/2021 - 05/2014
3	Intraocular Lenses (Intraocular Lens) 02/2024 - 12/2021
3	Aftercare (After-Treatment) 01/2022 - 06/2020
2	Phacoemulsification 02/2024 - 01/2021
2	Radiotherapy 11/2021 - 05/2014
2	Liver Transplantation 04/2020 - 01/2019